SiBone (SIBN) vs Tandem Diabetes Care, Inc. (TNDM)
- SiBone SIBN 24.48 +0.87%
- Tandem Diabetes Care, Inc. TNDM 16.69 −7.23%
SiBone and Tandem Diabetes Care, Inc. are both Medical Devices companies. Tandem Diabetes Care, Inc. is the larger, with a market value of $1.3B against $1.1B — 1.1× the size. SiBone grew revenue faster over the last twelve months: 14.0% against 6.84%. Tandem Diabetes Care, Inc. has the higher net margin (−4.58% vs −6.20%) and the higher return on invested capital (−5.35% vs −14.1%). Across the 18 metrics below, SiBone leads on 11 and Tandem Diabetes Care, Inc. on 7.
Valuation
Profitability
| Metric | SIBN | TNDM | Medical Devices median |
|---|---|---|---|
| Gross margin | 79.40% | 56.65% | 57.76% |
| Operating margin | (7.57%) | (2.35%) | (15.07%) |
| Net margin | (6.20%) | (4.58%) | (14.45%) |
| Free cash flow margin | (1.90%) | (3.37%) | (3.88%) |
| Return on equity | (7.67%) | (36.74%) | (10.35%) |
| Return on assets | (5.57%) | (4.84%) | (17.26%) |
| Return on invested capital | (14.10%) | (5.35%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack